Isoform-specific antagonists of exchange proteins directly activated by cAMP

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 45, 2012, Pages 18613-18618

  Tsalkova, Tamara ^a   Mei, Fang C ^a   Li, Sheng ^b   Chepurny, Oleg G ^c   Leech, Colin A ^c   Liu, Tong ^b   Holz, George G ^c   Woods, Virgil L ^b   Cheng, Xiaodong ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

cAMP regulated guanine nucleotide exchange factor; High throughput screening; Hydrogen deuterium exchange mass spectrometry

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEUTERIUM; EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CYCLIC AMP; EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CYCLIC AMP 2; GUANOSINE TRIPHOSPHATE; RAP1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL;

EID: 84868570315     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1210209109     Document Type: Article

References (41)

1. de Rooij J, et al. (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396(6710):474-477.
2. Kawasaki H, et al. (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282(5397):2275-2279. (Pubitemid 29004080)
3. Morel E, et al. (2005) cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ Res 97(12):1296-1304.
4. Métrich M, et al. (2008) Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 102(8):959-965. (Pubitemid 351591548)
5. Yokoyama U, et al. (2008) The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals. Proc Natl Acad Sci USA 105(17):6386-6391. (Pubitemid 351758355)
6. Villarreal F, Epperson SA, Ramirez-Sanchez I, Yamazaki KG, Brunton LL (2009) Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K. Am J Physiol Cell Physiol 296(5):C1178-C1184.
7. Insel PA, et al. (2012) cAMP and Epac in the regulation of tissue fibrosis. Br J Pharmacol 166(2):447-456.
8. Lorenz R, Aleksic T, Wagner M, Adler G, Weber CK (2008) The cAMP/Epac1/Rap1 pathway in pancreatic carcinoma. Pancreas 37(1):102-103.
9. Misra UK, Pizzo SV (2009) Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades. J Cell Biochem 108(4): 998-1011.
10. Baljinnyam E, et al. (2011) Epac1 promotes melanoma metastasis via modification of heparan sulfate. Pigment Cell Melanoma Res 24(4):680-687.
11. Fukuda M, Williams KW, Gautron L, Elmquist JK (2011) Induction of leptin resistance by activation of cAMP-Epac signaling. Cell Metab 13(3):331-339.
12. Kashima Y, et al. (2001) Critical role of cAMP-GEFII - Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 276(49):46046-46053.
13. Kang G, Chepurny OG, Holz GG (2001) cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic beta-cells. J Physiol 536(Pt 2):375-385. (Pubitemid 32976119)
14. Kang G, et al. (2003) Epac-selective cAMP analog 8-pCPT-2′-O-Me- cAMP as a stimulus for Ca2+ -induced Ca2+ release and exocytosis in pancreatic beta-cells. J Biol Chem 278(10):8279-8285. (Pubitemid 36800574)
15. Shibasaki T, et al. (2007) Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci USA 104(49):19333-19338.
16. Holz GG (2004) Epac: A new cAMP-binding protein in support of glucagon-like pep-tide- 1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 53 (1):5-13.
17. Zhang CL, et al. (2009) The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 325(5940):607-610.
18. Mukai E, et al. (2011) Exendin-4 suppresses SRC activation and reactive oxygen species production in diabetic Goto-Kakizaki rat islets in an Epac-dependent manner. Diabetes 60(1):218-226.
19. Woolfrey KM, et al. (2009) Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines. Nat Neurosci 12(10):1275-1284.
20. Penzes P, Woolfrey KM, Srivastava DP (2011) Epac2-mediated dendritic spine remodeling: Implications for disease. Mol Cell Neurosci 46(2):368-380.
21. Yang Y, et al. (2012) EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation. Neuron 73(4):774-788.
22. Cheng X, Ji Z, Tsalkova T, Mei F (2008) Epac and PKA: A tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin (Shanghai) 40(7):651-662. (Pubitemid 352009080)
23. Murray AJ (2008) Pharmacological PKA inhibition: All may not be what it seems. Sci Signal 1(22):re4.
24. Tsalkova T, Mei FC, Cheng X (2012) A fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic AMP (EPAC) antagonists. PLoS ONE 7(1):e30441.
25. Herbst KJ, Coltharp C, Amzel LM, Zhang J (2011) Direct activation of Epac by sulfonylurea is isoform selective. Chem Biol 18(2):243- 251.
26. Nikolaev VO, Bünemann M, Hein L, Hannawacker A, Lohse MJ (2004) Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 279(36): 37215-37218. (Pubitemid 39195424)
27. Allen MD, Zhang J (2006) Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochem Biophys Res Commun 348(2):716-721. (Pubitemid 44188622)
28. Brock M, et al. (2007) Conformational analysis of Epac activation using amide hydrogen/ deuterium exchange mass spectrometry. J Biol Chem 282(44):32256-32263. (Pubitemid 350106471)
29. Li S, et al. (2011) Mechanism of intracellular cAMP sensor Epac2 activation: cAMP-induced conformational changes identified by amide hydrogen/deuterium exchange mass spectrometry (DXMS). J Biol Chem 286(20):17889-17897.
30. Rehmann H, Das J, Knipscheer P, Wittinghofer A, Bos JL (2006) Structure of the cyclic- AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature 439(7076): 625-628. (Pubitemid 43185390)
31. Rehmann H, et al. (2008) Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 455(7209):124-127.
32. Mei FC, Cheng XD (2005) Interplay between exchange protein directly activated by cAMP (Epac) and microtubule cytoskeleton. Mol Biosyst 1(4):325-331. (Pubitemid 41579325)
33. Cheng X, Phelps C, Taylor SS (2001) Differential binding of cAMP-dependent protein kinase regulatory subunit isoforms Ialpha and IIbeta to the catalytic subunit. J Biol Chem 276(6):4102- 4108.
34. Yu S, Mei FC, Lee JC, Cheng X (2004) Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting. Biochemistry 43(7):1908-1920. (Pubitemid 38233253)
35. Tsalkova T, Blumenthal DK, Mei FC, White MA, Cheng X (2009) Mechanism of Epac activation: Structural and functional analyses of Epac2 hinge mutants with constitutive and reduced activities. J Biol Chem 284(35):23644-23651.
36. Cook PF, Neville ME, Jr., Vrana KE, Hartl FT, Roskoski R, Jr. (1982) Adenosine cyclic 3′,5′-monophosphate dependent protein kinase: Kinetic mechanism for the bovine skeletal muscle catalytic subunit. Biochemistry 21(23):5794-5799.
37. Qiao J, Mei FC, Popov VL, Vergara LA, Cheng X (2002) Cell cycle-dependent subcellular localization of exchange factor directly activated by cAMP. J Biol Chem 277(29): 26581-26586. (Pubitemid 34967156)
38. Pantazatos D, et al. (2004) Rapid refinement of crystallographic protein construct definition employing enhanced hydrogen/deuterium exchange MS. Proc Natl Acad Sci USA 101(3):751-756. (Pubitemid 38121030)
39. Hamuro Y, et al. (2004) Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS). J Mol Biol 340(5):1185-1196. (Pubitemid 38968710)
40. Chepurny OG, et al. (2009) Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: Studies with 8-pCPT-2′-O-Me-cAMP-AM. J Biol Chem 284(16):10728-10736.
41. Chepurny OG, et al. (2010) PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2′-O-Me- cAMP-AM in human islets of Langerhans. Am J Physiol Endocrinol Metab 298(3):E622-E633.